Abstract

Silica quantum dots (SiQDs) and their luminescent composites have displayed great potential for biomedical applications owing to their chemical inert and low cost. In this work, we report a facile, cost-effective and ultrafast strategy to prepare a stable luminescent SiQDs using N-[3-(trimethoxysilyl)propyl]ethylenediamine (EDAS) and salicylaldehyde as precursors for the first time. These luminescent SiQDs were further utilized for fabrication of luminescent mesoporous silica nanoparticles (MSNs) through direct encapsulation of SiQDs by MSNs. The novel synthetic and modified SiQDs uses commercial raw materials and the entire reaction can be completed within 30 s. The successful preparation of SiQDs and SiQDs@MSNs were characterized by various characterization equipments. The cell viability as well as cell uptake behavior of SiQDs@MSNs were also examined to evaluate their potential for biomedical applications. We demonstrated that these SiQDs@MSNs are low toxicity and of great potential for biological imaging. Based on the above results, we believe that these SiQDs@MSNs should be novel and promising candidates for biomedical applications owing to their intense fluorescence, biocompatibility and high specific surface areas.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.